Revance Therapeutics shares owned by Boothbay Fund Management
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Boothbay Fund Management
from 13F filings
Historical chart of Boothbay Fund Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Boothbay Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.2M | 2.0M | 3.04 |
| 2022-09-30 | $557k | 21k | 27.01 |
| 2021-09-30 | $233k | 8.4k | 27.89 |
| 2021-06-30 | $274k | 9.2k | 29.69 |
| 2020-09-30 | $395k | 16k | 25.13 |
| 2020-06-30 | $468k | 19k | 24.40 |
| 2020-03-31 | $354k | 24k | 14.81 |
| 2019-12-31 | $701k | 43k | 16.23 |
| 2018-03-31 | $335k | 11k | 30.80 |